Brian Berger Selected Research

ASP8232

1/2019

Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian Berger Research Topics

Disease

3	Macular Degeneration (Age-Related Maculopathy) 12/2021 - 10/2018
2	Neoplasms (Cancer) 07/2019 - 05/2019
2	Macular Edema 01/2019 - 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Choroidal Neovascularization 01/2020
1	Uveal melanoma 07/2019
1	Glioblastoma (Glioblastoma Multiforme) 05/2019
1	Melanoma (Melanoma, Malignant) 05/2019
1	Breast Neoplasms (Breast Cancer) 05/2019
1	Geographic Atrophy 10/2018
1	Cholestasis 11/2015

Drug/Important Bio-Agent (IBA)

3	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2018
1	carotuximabIBA 12/2021
1	faricimabIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Silicone OilsIBA 07/2019
1	Iodine-125IBA 07/2019
1	IntegrinsIBA 05/2019
1	matrigelIBA 05/2019
1	AntibodiesIBA 05/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	ASP8232IBA 01/2019
1	Amino Acids FDA Link 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	Amyloid (Amyloid Fibrils)IBA 10/2018
1	CC ChemokinesIBA 01/2018
1	PF-04634817IBA 01/2018
1	LigandsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2015

Therapy/Procedure

1	Intravitreal Injections 12/2021
1	Brachytherapy 07/2019
1	Vitrectomy 07/2019
1	Palliative Care (Palliative Therapy) 11/2015